ReviewObstetricsCare for women with prior preterm birth
Section snippets
The contribution of prior preterm birth to preterm birth in general
Approximately 13 million of the more than 130 million babies born annually worldwide are born preterm, a global incidence of nearly 10%.29 There are more than 500,000 births before 37 weeks' gestation in the United States each year, a rate of 12.7% in 2007.30 Of these, about 15% occur in women with a prior preterm birth.31 Current effective interventions could potentially eliminate as many as 35-50% of recurrent preterm births (n ∼ 37,000).
Identification of women with a prior preterm birth
A thorough obstetrical history is essential to identify women with prior preterm birth. Unfortunately, the nomenclature used to describe pregnancy outcomes, expressed as gravidity, parity (births after 20 menstrual weeks' gestation), and abortions (births before 20 weeks'), lacks a “clear epidemiologic, biologic, or clinical basis”26 and is inconsistent with recent obstetrical epidemiology: Women whose prior pregnancy ended between 16 and 20 weeks have a risk of recurrent preterm birth that
Document the clinical presentation of the prior preterm birth(s)
Preterm parturition is characterized by cervical ripening, decidual-membrane activation, and uterine contractions, any of which may predominate. The order in which these steps occurred can often be discerned from the history, offering clues to the etiology that can improve the prediction of recurrence risk. Obstetricians have traditionally been taught to ask about painful contractions as evidence that true labor has begun at term, but focusing on the presence and pain of contractions is
Recurrent vs nonrecurrent preterm birth
Women with recurrent preterm birth are more likely to have a low prepregnancy weight (below 100 pounds, with a body mass index <19.8 kg/m2) and to be African American than women with a single prior preterm birth.46, 47, 48, 49, 50, 51 The risk of recurrent preterm birth increases as the gestational age of the previous preterm birth declines and as the number of previous preterm births increases, and thus is highest in women with more than 1 early preterm birth.52 Women with more than 1 preterm
Estimation of individual risk of recurrent preterm birth
The risk of recurrent preterm birth is commonly reported to be increased by 1.5- to 2-fold to 4-fold or more, depending on the population. The risk increases with the number of prior preterm births and as the gestational age decreases (Figure 2 from McManemy et al52).
There are 3 historical factors that have a substantial influence on the likelihood of recurrent preterm birth. All are immediately available without cost: maternal race (African American vs all others), the gestational age of the
Interventions to reduce the risk of recurrent preterm birth
Numerous strategies and treatments have been proposed to reduce the risk of recurrent preterm birth, but few have been found effective when tested in clinical trials. The interventions in the following text are grouped according to the strength of evidence supporting their use:
Interventions supported by firm evidence
- •
Smoking-cessation programs: pregnant women are uniquely receptive to smoking-cessation programs, especially when physicians participate directly and repeatedly. Smoking-cessation programs in pregnancy have been reported to reduce the rate of preterm birth by 16% (relative risk, 0.84; 95% confidence interval [CI], 0.72–0.9862) to 31% (adjusted odds ratio [aOR], 0.69; 95% CI, 0.65–0.74).63
- •
Screening and treatment for asymptomatic bacteriuria: screening for asymptomatic bacteriuria reduces
Interventions suggested to reduce the risk of recurrent preterm birth for which evidence is absent, minimal, or mixed
- •
Surveillance of cervical length with transvaginal ultrasound has never been compared to digital or no cervical examination in a randomized trial of women with a prior preterm birth. Cervical ultrasound can reveal and quantify changes in the cervix sooner and more reproducibly than digital examination.77, 78 However, the effect of cervical sonography on outcomes has not been demonstrated, and experience with ambulatory uterine contraction monitoring has shown that more information does not
Interventions that have been shown to be ineffective to reduce the risk of recurrent preterm birth
- •
Nutritional supplements: randomized, placebo-controlled trials of vitamins C and E have not found any reduction in preterm birth.101, 102
- •
Early detection of preterm labor (PTL): small early trials suggested benefit, but subsequent randomized trials of programs to detect PTL, including provider-initiated care, frequent nurse contact, and outpatient home uterine contraction monitoring, did not reveal reduction of recurrent preterm birth.7
- •
Contraction suppression: contraction suppression with
The context of prenatal care for women with a prior PTB
Women with a prior PTB may have lower rates of recurrent PTB when prenatal care includes specific attention to open communication between the patient and her caregivers. Lower rates of PTB have been reported in observational studies of provider-initiated contact,110 family nurse partnerships, and special programs for women with previous PTB.111 Because the clinical presentation of preterm parturition is more subtle than parturition at term, early signs and symptoms such as pelvic pressure and
The future of prenatal care for women with prior PTB
Selective use of progestational agents and cerclage112 is guided primarily by a clinical history of spontaneous PTB or repetitive midpregnancy loss, respectively. Neither is fully effective in all women with these historical indications. As experience with progesterone supplementation grows, prophylaxis may be reserved for women with a prior PTB who also manifest another marker for PTB, such as a short cervix, a positive test for cervical inflammation, and/or who are found to have a genetic
Key points that summarize the authors' approach to prenatal care for women with a prior preterm birth
- •
Obtain a thorough history and records for all prior pregnancies.
- •
Try to determine the pathways that led to the prior PTB and categorize it as likely or unlikely to recur.
- •
Estimate the woman's personal risk of another PTB.
- •
Identify and eliminate or minimize other risk factors.
- •
Establish welcoming methods of communication between women with prior PTB and knowledgeable caregivers.
- •
Assess personal and family resources and barriers to receiving care.
- •
Apply evidence-based interventions for women with prior
Acknowledgments
Dr Berghella is currently participating in a prospective trial of vaginal progesterone to prevent preterm birth in high-risk women sponsored by Columbia Laboratories, makers of the product being studied in the trial. Neither of the authors receives money from, owns stock in, or speaks on behalf of Columbia Laboratories.
References (112)
- et al.
The therapeutic value of maintenance tocolysis: an overview of the evidence
Clin Perinatol
(2003) - et al.
Interconceptional antibiotics to prevent spontaneous preterm birth: a randomized clinical trial
Am J Obstet Gynecol
(2006) - et al.
Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women
Obstet Gynecol
(2003) - et al.
Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous PTB in women at increased risk: a randomized placebo-controlled double-blind study
Am J Obstet Gynecol
(2003) - et al.
Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery
Am J Obstet Gynecol
(2005) - et al.
Multicenter randomized trial of cerclage for prevention of preterm birth in high-risk women with shortened mid-trimester cervical length
Am J Obstet Gynecol
(2009) - et al.
The preterm prediction study: fetal fibronectin, bacterial vaginosis and peripartum infection
Obstet Gynecol
(1996) - et al.
Second trimester loss and subsequent pregnancy outcomes: what is the real risk?
Am J Obstet Gynecol
(2007) - et al.
The association between stillbirth in the first pregnancy and subsequent adverse perinatal outcomes
Am J Obstet Gynecol
(2009) - et al.
Impact of induced abortions on subsequent pregnancy outcome: the 1995 French national perinatal survey
BJOG
(2001)
Prognostic significance of prior preterm twin delivery on subsequent singleton pregnancy
Am J Obstet Gynecol
Are women who have had a preterm twin delivery at greater risk of preterm birth in a subsequent singleton pregnancy?
Am J Obstet Gynecol
Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonaodtropin and the risk of adverse outcomes
Am J Obstet Gynecol
Birth weight is lower for survivors of the vanishing twin syndrome: a case-control study
Fertil Steril
Racial disparity in the frequency of recurrence of PTB
Am J Obstet Gynecol
The preterm prediction study: effect of gestational age and cause of PTB on subsequent pregnancy outcome
Am J Obstet Gynecol
Periviable birth at 20-26 weeks of gestation: proximate causes, previous obstetric history and recurrence risk
Am J Obstet Gynecol
The preterm prediction study: recurrence risk of spontaneous PTB
Am J Obstet Gynecol
Rates of recurrent preterm birth by obstetrical history and cervical length
Am J Obstet Gynecol
Oral micronized progesterone for prevention of preterm birth
Internat J Gynecol Obstet
Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate
Am J Obstet Gynecol
Cervical incompetence prevention randomized cerclage trial (CIPRACT): study design and preliminary results
Am J Obstet Gynecol
A randomized controlled trial of cervical scanning vs history to determine cerclage in women at high risk of preterm birth (CIRCLE trial)
Am J Obstet Gynecol
Impact of a ‘rescue course’ of antenatal corticosteroids: a multicenter randomized placebo-controlled trial
Am J Obstet Gynecol
Ultrasonographic examination of the cervix is better than cervical digital examination as a predictor of preterm delivery in patients with preterm labor and intact membranes
Am J Obstet Gynecol
Interobserver reliability of digital and endovaginal ultrasonographic cervical length measurements
Am J Obstet Gynecol
Cervical incompetence prevention randomized cerclage trial: emergency cerclage with bed rest versus bed rest alone
Am J Obstet Gynecol
Expectant management compared with physical examination-indicated cerclage (EM-PEC) in selected women with a dilated cervix at 14(0/7)-25(6/7) weeks: results from the EM-PEC international cohort study
Am J Obstet Gynecol
Patients with a prior failed transvaginal cerclage: a comparison of obstetric outcomes with either transabdominal or transvaginal cerclage
Am J Obstet Gynecol
The West Los Angeles preterm birth prevention project. I. Program impact on high-risk women
Am J Obstet Gynecol
Preterm birth prevention: evaluation of a prospective controlled trial
Am J Obstet Gynecol
Betamimetics for inhibiting preterm labour
Cochrane Database Syst Rev
Calcium channel blockers for inhibiting preterm labour
Cochrane Database Syst Rev
Cyclo-oxygenase (COX) inhibitors for treating preterm labour
Cochrane Database Syst Rev
Magnesium sulphate for preventing preterm birth in threatened preterm labour
Cochrane Database Syst Rev
Oxytocin receptor antagonists for inhibiting preterm labour
Cochrane Database Syst Rev
Frequency of uterine contractions and the risk of spontaneous preterm delivery
N Engl J Med
Monitoring women at risk for preterm labor
N Engl J Med
ACOG practice bulletin no. 31
Obstet Gynecol
A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fFN: the PREMET Study
BJOG
Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomized placebo-controlled double-blind trial
BJOG
Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection
N Engl J Med
Treatment of vaginal infections to prevent preterm birth: a meta-analysis
Clin Obstet Gynecol
Prophylactic antibiotic administration in pregnancy to prevent infectious morbidity and mortality
Cochrane Database Syst Rev
Antibiotics for treating bacterial vaginosis in pregnancy
Cochrane Database Syst Rev
Prevention of recurrent preterm delivery by 17-alpha-hydroxyprogesterone caproate
N Engl J Med
Progesterone and the risk of preterm birth among women with a short cervix
N Engl J Med
A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins
N Engl J Med
Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial
Obstet Gynecol
Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data
Obstet Gynecol
Cited by (145)
The effect of chorionicity on maternal and neonatal outcomes in triplet pregnancies
2024, European Journal of Obstetrics and Gynecology and Reproductive BiologyThe role of neighborhood deprivation in the cervicovaginal microbiota
2024, American Journal of Obstetrics and Gynecology MFMReview paper: The importance of consideration of collagen cross-links in computational models of collagen-based tissues
2023, Journal of the Mechanical Behavior of Biomedical MaterialsWhat now? A critical evaluation of over 20 years of clinical and research experience with 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention
2023, American Journal of Obstetrics and Gynecology MFMHealthy preconception and early-pregnancy lifestyle and risk of preterm birth: a prospective cohort study
2021, American Journal of Clinical Nutrition
Reprints not available from the authors.